Cargando…

Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials

BACKGROUND: The influence of sugammadex for reversal of neuromuscular block (NMB) on postoperative pulmonary complications (PPCs), compared with neostigmine, remains to be determined. We performed a meta-analysis of randomized controlled trials (RCTs) to compare the incidence of PPCs between patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jia-Feng, Zhao, Zhen-Zhen, Jiang, Zheng-Yu, Liu, Hui-Xing, Deng, Xiao-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451127/ https://www.ncbi.nlm.nih.gov/pubmed/34538277 http://dx.doi.org/10.1186/s13741-021-00203-6

Ejemplares similares

Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.
por: Lemmens, Hendrikus JM, et al.
Publicado: (2010)

Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery
por: Traeger, L., et al.
Publicado: (2022)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
por: Ren, Maodong, et al.
Publicado: (2020)

An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023)

Sugammadex, neostigmine and postoperative pulmonary complications: an international randomised feasibility and pilot trial
por: Leslie, Kate, et al.
Publicado: (2021)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)

A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada
por: Insinga, Ralph P., et al.
Publicado: (2016)

Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Paredes, Stephania, et al.
Publicado: (2023)

The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex
por: Oh, Tak Kyu, et al.
Publicado: (2019)

Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3
por: He, Jing, et al.
Publicado: (2021)

Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery
por: Oh, Tak Kyu, et al.
Publicado: (2020)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
por: Alsaeed, Abdulhamid, et al.
Publicado: (2017)

Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial
por: Wang, Xuan, et al.
Publicado: (2021)

Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency
por: Deyhim, Niaz, et al.
Publicado: (2020)

Data and meta-analysis for choosing sugammadex or neostigmine for routine reversal of rocuronium block in adult patients
por: Hurford, William E., et al.
Publicado: (2020)

Efficacy and Safety of Sugammadex versus Neostigmine in Reversing Neuromuscular Blockade in Morbidly Obese Adult Patients: A Systematic Review and Meta-Analysis
por: Subramani, Yamini, et al.
Publicado: (2021)

Cost-Effectiveness of Sugammadex Versus Neostigmine to Reverse Neuromuscular Blockade in a University Hospital in Taiwan: A Propensity Score-Matched Analysis
por: Lan, Winnie, et al.
Publicado: (2023)

Effects of Sugammadex and Neostigmine on Renal Biomarkers
por: Isik, Yasemin, et al.
Publicado: (2016)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Effects of Neostigmine and Sugammadex for Reversal of Neuromuscular Blockade on QT Dispersion Under Propofol Anesthesia: A Randomized Controlled Trial
por: Yamashita, Yusuke, et al.
Publicado: (2018)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
por: Han, Jiwon, et al.
Publicado: (2021)

Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center
por: Fiorda Diaz, Juan, et al.
Publicado: (2022)

Effects of Sugammadex versus Neostigmine on Intraoperative Coagulation Profiles in Patients with Thyroidectomy
por: Zhao, Dizhou, et al.
Publicado: (2021)

Neostigmine versus sugammadex on post-operative recovery following bariatric surgery
por: Ekinci, Osman, et al.
Publicado: (2022)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Successful Neuromuscular Blockade Reversal Using Sugammadex and Neostigmine Failed to Prevent Myasthenic Crisis After Emergency Surgery: A Case Report
por: Haddad, Daniel, et al.
Publicado: (2022)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects
por: Wu, Xinmin, et al.
Publicado: (2014)

Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis
por: Liu, Hong-Mei, et al.
Publicado: (2023)

Comparison of neostigmine and sugammadex for hemodynamic parameters in neurointerventional anesthesia
por: Tsai, Yu-Hsun, et al.
Publicado: (2023)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

Superiority of sugammadex in preventing postoperative pulmonary complications
por: Liu, Haibei, et al.
Publicado: (2023)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpi2h71s27ai8scdrvt6qp267b